- Home
- ATRC vs EEX Comparison
ATRC vs EEX Comparison
Compare ATRC & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- EEX
- Stock Information
- Founded
- ATRC 2000
- EEX 2013
- Country
- ATRC United States
- EEX United States
- Employees
- ATRC N/A
- EEX N/A
- Industry
- ATRC Medical/Dental Instruments
- EEX Advertising
- Sector
- ATRC Health Care
- EEX Consumer Discretionary
- Exchange
- ATRC Nasdaq
- EEX Nasdaq
- Market Cap
- ATRC 1.1B
- EEX 931.7M
- IPO Year
- ATRC 2005
- EEX 2017
- Fundamental
- Price
- ATRC $34.52
- EEX $3.91
- Analyst Decision
- ATRC Strong Buy
- EEX Strong Buy
- Analyst Count
- ATRC 10
- EEX 2
- Target Price
- ATRC $50.40
- EEX $7.90
- AVG Volume (30 Days)
- ATRC 588.5K
- EEX 163.5K
- Earning Date
- ATRC 04-30-2025
- EEX 03-14-2025
- Dividend Yield
- ATRC N/A
- EEX 1.15%
- EPS Growth
- ATRC N/A
- EEX N/A
- EPS
- ATRC N/A
- EEX N/A
- Revenue
- ATRC $465,307,000.00
- EEX $393,500,000.00
- Revenue This Year
- ATRC $14.60
- EEX $5.54
- Revenue Next Year
- ATRC $12.66
- EEX $7.75
- P/E Ratio
- ATRC N/A
- EEX N/A
- Revenue Growth
- ATRC 16.55
- EEX 4.96
- 52 Week Low
- ATRC $18.94
- EEX $3.88
- 52 Week High
- ATRC $43.11
- EEX $7.05
- Technical
- Relative Strength Index (RSI)
- ATRC 33.27
- EEX 21.28
- Support Level
- ATRC $36.68
- EEX $3.93
- Resistance Level
- ATRC $39.71
- EEX $4.02
- Average True Range (ATR)
- ATRC 1.75
- EEX 0.13
- MACD
- ATRC -0.63
- EEX -0.02
- Stochastic Oscillator
- ATRC 9.94
- EEX 5.08
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About EEX Emerald Holding Inc.
Emerald Holding Inc is an operator of B2B trade shows in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry, Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. Majority of the revenue for the company is generated from its Connections segment.